of 15% acetic acid in water. Once fully
dissolved dilute the solution 5-fold with water.
3. Mix 220 µl of tRNA solution (step 1) with
2.5 µl of Pyronin Y solution (step 2). Equilibrate at
22
of 15% acetic acid in water. Once fully
dissolved dilute the solution 5-fold with water.
3. Mix 220 µl of tRNA solution (step 1) with 2.5 µl of
Pyronin Y solution (step 2). Equilibrate at
271-280.e8
(2020).
8. Lan, J. et al., Nature, 581(7807), 215-220
(2020).
9. Liu, Z. et al., J. Med. Virol., 92(6), 595-601
(2020).
10. Luan, J. et al., Biochem. Biophys. Res. Commun.
271-280.e8
(2020).
8. Lan, J. et al., Nature, 581(7807), 215-220
(2020).
9. Liu, Z. et al., J. Med. Virol., 92(6), 595-601
(2020).
10. Luan, J. et al., Biochem. Biophys. Res. Commun.
271-280.e8
(2020).
8. Lan, J. et al., Nature, 581(7807), 215-220
(2020).
9. Liu, Z. et al., J. Med. Virol., 92(6), 595-601
(2020).
10. Luan, J. et al., Biochem. Biophys. Res. Commun.
DL. Systems cell biology based on high-content
screening. Methods Enzymol. 2006;414:601-619. PMID: 17110213
3. Gough AH, Johnston PA.Requirements, features, and performance of high content screening
Activity Mediates the Differentiation of Embryonic Stem Cells. Cell Stem Cell.
2008 Jun 5;2(6):595-601.
3. Melton, D et al. Wnt signaling specifies and patterns intestinal endoderm. Mechanisms of Development
-Catenin
Monoclonal Antibody
Anti-β-Catenin (non-phospho) 8E4 H M R WB IP Pur M IgG1κ 100 µg 05-601
Anti-β-Catenin 2H4A7 H M R WB IP IH Pur M IgG 200 µg 05-613
Anti-Active-β-Catenin (anti-ABC)
955794.1 n/d n/d y
473 Munc-13/1 M6194 382018 Unc13a M NP_001025044.2 n/d y y
220 DcR3 D1814 497118 Dcr3 P y y y
1 14-3-3 q/t14-3-3 T5942 546165 EG546165 MEG546165 y y y
2 Acetylated Protein A5463 NA NA P y
955794.1 n/d n/d y
473 Munc-13/1 M6194 382018 Unc13a M NP_001025044.2 n/d y y
220 DcR3 D1814 497118 Dcr3 P y y y
1 14-3-3 q/t14-3-3 T5942 546165 EG546165 MEG546165 y y y
2 Acetylated Protein A5463 NA NA P y
955794.1 n/d n/d y
473 Munc-13/1 M6194 382018 Unc13a M NP_001025044.2 n/d y y
220 DcR3 D1814 497118 Dcr3 P y y y
1 14-3-3 q/t14-3-3 T5942 546165 EG546165 MEG546165 y y y
2 Acetylated Protein A5463 NA NA P y
P5999 M n/d y y
598 PRMT1 P6871 P y n/d n/d
599 PRMT1 P6996 P y y y
600 Anti Cy3+Cy5 C0992 M NA NA NA
601 PRMT2 P0748 M y n/d n/d
602 PRMT3 P9370 M y y y
603 PRMT4 P4995 P y
y n/d n/d
599 PRMT1 P6996 15469, 3276 Prmt1,PRMT1 NP_062804.1,NP_938075.2 P y y y
600 Anti Cy3+Cy5
601 PRMT2 P0748 3275 PRMT2 NP_996845.1 M y n/d n/d
602 PRMT3 P9370 10196 PRMT3 NP_005779.1 M y y y
603
n/d
599 PRMT1 P6996 15469, 3276 Prmt1,PRMT1 NP_062804.1,NP_938075.2 P y y y
600 Anti Cy3+Cy5 C0992
601 PRMT2 P0748 3275 PRMT2 NP_996845.1 M y n/d n/d
602 PRMT3 P9370 10196 PRMT3 NP_005779.1 M y y y
603